Biotech one step closer to bowel disease treatment
Monday, August 22, 2016 - 12:04
in Health & Medicine
University of Queensland spin-out biotech company Protagonist Therapeutics Inc is a step closer to developing a new drug that would benefit millions of people worldwide. The company is headquartered in California with research operations at UQ’s Institute for Molecular Bioscience in Brisbane. It is working on the development of peptide-based oral drugs to treat inflammatory […]